Clinical Trials Logo

Eye Infections clinical trials

View clinical trials related to Eye Infections.

Filter by:

NCT ID: NCT00564447 Completed - Clinical trials for Bacterial Infections

Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers

Start date: December 2007
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the drug concentrations of AzaSiteā„¢ compared to Vigamox at various time points in conjunctiva tissue of healthy volunteers

NCT ID: NCT00357539 Completed - Clinical trials for Eye Infections, Bacterial

Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers

Start date: February 2002
Phase: Phase 1
Study type: Interventional

To compare the ocular tolerance, safety and ocular pharmacokinetics of 3 concentrations (0.5% - 1.0% - 1.5%) and the vehicle of T1225.

NCT ID: NCT00357383 Completed - Clinical trials for Eye Infections, Bacterial

Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers

Start date: October 2002
Phase: Phase 1
Study type: Interventional

To evaluate the ocular tolerance of T1225 1% and 1.5% eye drops versus vehicle after one instillation twice-daily (morning and evening), in one eye, during 3 days (from Day 0 to Day 2). To assess azithromycin tear, conjunctiva and plasmatic concentrations, after a 3-day treatment period

NCT ID: NCT00357292 Completed - Clinical trials for Eye Infections, Bacterial

Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers

Start date: March 2002
Phase: Phase 1
Study type: Interventional

To compare the ocular tolerance, the safety and the ocular pharmacokinetics of 3 concentrations (0.5% - 1.0% - 1.5%) and the vehicle of T1225 after one drop instillation

NCT ID: NCT00356850 Completed - Clinical trials for Eye Infections, Bacterial

Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy Volunteers

Start date: May 2002
Phase: Phase 1
Study type: Interventional

To evaluate azithromycin tear concentrations after instillation of one drop of one of the three T1225 concentrations (0.5%, 1% and 1.5%) and to evaluate the ocular safety.

NCT ID: NCT00356772 Completed - Clinical trials for Eye Infections, Bacterial

Azithromycin Level in Tears and in Conjunctiva in 36 Healthy Volunteers

Start date: February 2003
Phase: Phase 1
Study type: Interventional

To evaluate azithromycin ocular conjunctiva concentrations 7 and 14 days after treatment initiation. To assess ocular and systemic tolerance/safety and azithromycin tear concentrations on Day 7

NCT ID: NCT00347828 Active, not recruiting - Infection Clinical Trials

Effectiveness Study of Zymar Versus Vigamox for Preoperative Sterilization of the Ocular Surface After Loading Dose

Start date: June 2006
Phase: Phase 4
Study type: Interventional

The purpose of this study is to analyze the effect of Zymar and Vigamox on ocular surface bacteria. We believe that Zymar will eradicate more ocular surface bacteria than Vigamox.

NCT ID: NCT00335088 Unknown status - Eye Infections Clinical Trials

Local Moxifloxacin and Povidone Iodine Versus Povidone Iodine Alone as a Prophylaxis Before Eye Operations

Start date: June 2006
Phase: Phase 3
Study type: Interventional

The hypothesis is that povidone iodine alone is sufficient for sterilization of the lacrimal sac and eye lids before intraocular surgeries. Patients admitted for various intraocular surgeries will be randomly allocated to prophylactic local therapy with either moxifloxacin and povidone iodine or povidone iodine alone before surgery. Lacrimal sac and eye lid cultures will be obtained before the local therapy and just before surgery.

NCT ID: NCT00324168 Completed - Corneal Ulcer Clinical Trials

Steroids for Corneal Ulcers Trial

SCUT
Start date: September 2006
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether adding topical steroids improves the outcomes of bacterial corneal ulcers, especially visual acuity.

NCT ID: NCT00198523 Completed - Clinical trials for Postoperative Complications

A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte

Start date: July 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the bioequivalence of the combination test agent, prednisolone acetate 1.0% and tobramycin 0.3% ophthalmic suspension compared to PredForte (prednisolone acetate 1.0%) ophthalmic suspension. Bioequivalence will be measured by comparing aqueous humor concentrations of prednisolone acetate.